Plexus Corp. (NASDAQ:PLXS – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $276.86.
Several brokerages recently issued reports on PLXS. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a report on Friday, July 31st. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. KeyCorp upgraded shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price target for the company in a research report on Monday, September 21st. Weiss Ratings cut shares of Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday. Finally, Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research note on Saturday.
Check Out Our Latest Analysis on PLXS
Insider Buying and Selling
In related news, CEO Todd Kelsey sold 1,500 shares of the stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $250.98, for a total transaction of $376,470.00. Following the completion of the transaction, the chief executive officer owned 65,888 shares of the company’s stock, valued at approximately $16,536,570.24. This trade represents a 2.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of Plexus stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $240.87, for a total transaction of $120,435.00. Following the completion of the sale, the director owned 7,535 shares of the company’s stock, valued at $1,814,955.45. This trade represents a 6.22% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 9,000 shares of company stock valued at $2,319,260. Company insiders own 1.78% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of PLXS. Signaturefd LLC raised its stake in shares of Plexus by 6.1% in the third quarter. Signaturefd LLC now owns 1,765 shares of the technology company’s stock valued at $461,000 after acquiring an additional 101 shares in the last quarter. Sowell Financial Services LLC purchased a new position in Plexus in the third quarter valued at $224,000. Gibbs Wealth Management grew its stake in Plexus by 114.5% during the 3rd quarter. Gibbs Wealth Management now owns 3,512 shares of the technology company’s stock worth $916,000 after purchasing an additional 1,875 shares in the last quarter. Fifth Third Wealth Advisors LLC grew its stake in Plexus by 185.2% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 4,755 shares of the technology company’s stock worth $1,241,000 after purchasing an additional 3,088 shares in the last quarter. Finally, Sterling Capital Management LLC grew its stake in Plexus by 841.1% during the 3rd quarter. Sterling Capital Management LLC now owns 894 shares of the technology company’s stock worth $233,000 after purchasing an additional 799 shares in the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Plexus Price Performance
PLXS stock opened at $216.98 on Friday. Plexus has a 52-week low of $132.03 and a 52-week high of $307.06. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. The stock has a market cap of $5.81 billion, a price-to-earnings ratio of 32.00 and a beta of 0.88. The business has a fifty day moving average of $249.62 and a two-hundred day moving average of $258.33.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating the consensus estimate of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%. The company’s quarterly revenue was up 28.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, research analysts anticipate that Plexus will post 7.13 earnings per share for the current year.
About Plexus
Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.
Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
Further Reading
- Five stocks we like better than Plexus
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
